Optimizing the use of prescription drugs in Canada through the Common Drug Review

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 4, 2008, Pages 432-435

  Tierney, Mike ^a   Manns, Braden ^a,b   Bassett, Ken ^c   Carleton, Bruce ^c   Conly, John M ^d   Evans, Michael ^e   Holbrook, Anne ^f   Mallery, Laurie ^g   Man Son Hing, Malcolm ^h   Peterson, Robert ^c   Quest, Dale ⁱ   McColl, Nancy ^j   Neubauer, Brad ^j  

^a CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ UNIVERSITY OF SASKATCHEWAN   (Canada)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

CANADA; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULARY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG SAFETY; DRUG SCREENING; HEALTH CARE COST; HUMAN; MEDICAL INFORMATION SYSTEM; NOTE; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PROSPECTIVE PRICING;

EID: 39749167863     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070713     Document Type: Note

References (10)